145 related articles for article (PubMed ID: 3844972)
1. Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
Flodgren P; Sjögren HO
Cancer Immunol Immunother; 1985; 19(1):28-34. PubMed ID: 3844972
[TBL] [Abstract][Full Text] [Related]
2. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
Hirai N; Hill NO; Motoo Y; Osther K
Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
[TBL] [Abstract][Full Text] [Related]
3. Recombinant leukocyte A interferon as single agent therapy or in combination with cimetidine in patients with advanced colo-rectal carcinoma. A phase II investigation.
Flodgren P; Hugander A; Sjögren HO
Acta Radiol Oncol; 1985; 24(1):25-34. PubMed ID: 2984899
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the in vivo and in vitro effects of indomethacin on human natural killer cell activity.
Pedersen BK; Oxholm P; Klarlund K
Allergy; 1986 Sep; 41(7):532-6. PubMed ID: 3789334
[TBL] [Abstract][Full Text] [Related]
5. Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine.
Flodgren P; Malmström P; Axelsson B; Boketoft A; Borgström S; Sjögren HO
Anticancer Res; 1985; 5(2):197-204. PubMed ID: 3994311
[TBL] [Abstract][Full Text] [Related]
6. Augmented natural killer activity in ovarian cancer patients treated with cimetidine.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1037-43. PubMed ID: 3780810
[TBL] [Abstract][Full Text] [Related]
7. The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate.
Lahat N; Alexander B; Levin DR; Moskovitz B
Cancer Immunol Immunother; 1989; 28(3):208-12. PubMed ID: 2784355
[TBL] [Abstract][Full Text] [Related]
8. Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro.
Nair MP; Schwartz SA
Cell Immunol; 1983 Oct; 81(1):45-60. PubMed ID: 6225527
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
Sibbitt WL; Mathews PM; Bankhurst AD
J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
[TBL] [Abstract][Full Text] [Related]
10. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.
Herberman RR; Ortaldo JR; Bonnard GD
Nature; 1979 Jan; 277(5693):221-3. PubMed ID: 95205
[No Abstract] [Full Text] [Related]
11. Histamine H2-receptor-mediated regulation of human natural killer cell activity.
Hellstrand K; Hermodsson S
J Immunol; 1986 Jul; 137(2):656-60. PubMed ID: 3722819
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
13. Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.
Tank B; Marquet RL; Weimar W; Westbroek DL
Br J Cancer; 1984 Aug; 50(2):227-30. PubMed ID: 6466539
[No Abstract] [Full Text] [Related]
14. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
[TBL] [Abstract][Full Text] [Related]
15. Influence of human leukocyte interferon (HuIFN-alpha/Le/) and cimetidine on the proliferation of cultured melanoma cells in vitro.
Flodgren P
Anticancer Res; 1985; 5(5):527-31. PubMed ID: 4062254
[TBL] [Abstract][Full Text] [Related]
16. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
Nair MP; Schwartz SA; Menon M
Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
18. Modulation of natural killer activity by aspirin: I. In vitro effect of aspirin.
Porzsolt F; Wolf W
J Interferon Res; 1983; 3(1):11-7. PubMed ID: 6842038
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
Lieberman MD; Sigal RK; Williams NN; Daly JM
J Surg Res; 1991 Apr; 50(4):410-5. PubMed ID: 1673486
[TBL] [Abstract][Full Text] [Related]
20. Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.
Merrill JE
J Clin Immunol; 1983 Jan; 3(1):42-50. PubMed ID: 6219125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
